US67079U3068
US67079U3068
Nutex Health Inc.
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 | Q4 '25 31.12.2025 |
|---|---|---|---|---|
Market & Enterprise Value | ||||
Market Cap | 1.41B EUR | 1.17B EUR | 660.68M EUR | 1.17B EUR |
Enterprise Value | 1.66B EUR | 1.31B EUR | 802.42M EUR | 1.33B EUR |
Valuation Multiples | ||||
Trailing P/E | 8.17x | 6.5x | 6.86x | 23.53x |
Forward P/E | 10.15x | -- | -- | -- |
Price to Sales | 1.67x | 1.38x | 0.75x | 1.76x |
Price to Book | 3.58x | 2.97x | 1.91x | 3.54x |
EV/Revenue | 1.96x | 1.55x | 0.91x | 2.01x |
EV/EBITDA | 3.3x | 3.41x | 2.75x | 6.5x |
Price to FCF (P/FCF) | 10.8x | 4.27x | 2.46x | 5.99x |
EV/FCF | 12.69x | 4.78x | 2.98x | 6.84x |
FCF Yield | 9.26% | 23.44% | 40.72% | 16.69% |